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ABSTRAK 
TARIGAN, S. 2006. Vaksinasi kambing dengan ekstrak segar Sarcoptes scabiei menghasilkan kekebalan parsial. JITV 11(2): 144-
150. 
Telah diketahui bahwa kekebalan yang melindungi terbentuk saat Sarcoptes scabiei menginfestasi hewan. Akan tetapi pada 
penelitian terdahulu usaha untuk menginduksi kekebalan dengan memvaksin kambing dengan fraksi protein tungau baik yang 
larut maupun yang ‘nirlarut’ tidak berhasil. Degradasi atau denaturasi protektif antigen saat preparasi vaksin merupakan salah 
satu kemungkinan kegagalan tersebut. Pada penelitian ini, protein tungau yang dipakai disiapkan dengan cepat untuk 
menghindari terjadinya degradasi atau denaturasi protein. Sebanyak 150 mg tungau yang baru saja diisolasi dengan cepat 
dihomogenisasi, disentrifus dan dipisahkan menjadi fraksi supernatan dan pelet. Sebanyak 28 kambing dibagi menjadi 4 
kelompok sama banyak. Kelompok 1 divaksin dengan keseluruhan homogenat, kelompok 2 dengan supernatan, kelompok 3 
dengan pelet, dan kelompok 4 dengan PBS (kontrol). Vaksinasi dilakukan sebanyak 3 kali, dengan interval 3 minggu, 
menggunakan Quil A sebagai adjuvan, dan setiap vaksinasi menggunakan homogenat yang segar. Satu minggu setelah vaksinasi 
terakhir, semua kambing ditantang dengan kira-kira 2000 tungau hidup. Keparahan lesi, yang diskor dari 0 (tanpa lesi) sampai 5 
(>75% telinga yang tekena lesi) ditentukan satu hari, dua hari, lalu setiap minggu pasca tantang. Kerokan kulit untuk 
menentukan densitas tungau diambil delapan minggu pasca tantang. Penantangan dengan tungau menyebabkan terbentuknya lesi 
kulit pada semua hewan. Tidak ada perbedaan yang nyata antara kelompok hewan yang divaksin dengan yang tidak divaksin 
dalam hal keparahan lesi. Akan tetapi, densitas tungau pada kelompok hewan yang divaksin secara nyata (P = 0,015) lebih 
rendah dibandingkan dengan hewan yang tidak divaksin. Penelitian ini memberi indikasi bahwa protektif antigen S. scabiei 
sangat rentan terhadap degradasi atau denaturasi, dan terdapat dalam konsentrasi atau antigenisitas yang sangat rendah. Oleh 
karena itu metoda konvensional, fraksinasi keseluruhan protein tungau dan pengujian setiap fraksi dengan uji vaksinasi, 
kelihatannya tidak cocok untuk S. scabiei. 
Kata Kunci: Sarcoptes scabiei, Vaksinasi, Homogenat Segar, Partial Immunity 
ABSTRACT 
TARIGAN, S. 2006. Vaccination of goats with fresh extract from Sarcoptes scabiei confers partial protective immunity. JITV 
11(2): 144-150. 
Protective immunity has been known to develop in animals infested with Sarcoptes scabiei. However, our previous attempt 
to induce protective immunity in goats by vaccination with fractions of soluble or insoluble mite proteins had been unsuccessful. 
Degradation or denaturation of protective antigens occurred during vaccine preparation was suggested as one possible cause of 
the failure. In this study, mite proteins that used to immunise animals were prepared rapidly in order to prevent protein 
degradation or denaturation. About 150 mg of freshly isolated mites were rapidly homogenised, centrifuged then separated into 
supernatant and pellet fractions. Twenty-eight goats were allocated equally into 4 groups. Group-1 goats were vaccinated with 
the whole mite homogenate supernatant, group 2 with the supernatant, group 3 with the pellet, and group 4 with PBS 
(unvaccinated control). Vaccination was conducted three times, with three-week intervals between vaccinations, using Quil A as 
adjuvant, and each vaccination using fresh mite homogenates. One week after the last vaccination, all animals were challenged 
with approximately 2000 live mites. The severity of lesions, scored from 0 (no lesions) to 5 (>75% infested auricle affected), 
were determined one day, two days, then every week after challenge. Mite challenge caused the development of skin lesions in 
all animals. No significant differences between vaccinated and unvaccinated animals were observed in regards to the severity of 
lesions. However, the mite densities in vaccinated animals were significantly lower (P=0.015) than those in unvaccinated 
control. This study indicates that the protective antigens of S. scabiei are liable to degradation or denaturation and exist in a very 
low concentration or have vary low antigenicity. This implies isolation of the protective antigens by the conventional approach, 
fracionation of the whole mite proteins and testing each fractions in vaccination trials, is seemingly inappropriate for S. scabiei. 
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INTRODUCTION 
Scabies or sarcoptic mange, a contagious pruritic 
disease caused by Sarcoptes scabiei, is one of the most 
important disease in man and animals. It is estimated 
that over 300 million people are infected every year 
(ARLIAN, 1989). In animals, it is reported that more 
than 40 species of mitos from 17 families and seven 
orders of mammals (ZAHLER et al., 1999). In domestic 
animals, pigs and goats seem to be the most susceptible, 
whereas in pet animals, the disease is most common in 
dogs. In wild animals, outbreaks of disease resulted in 
high mortality have been reported in gorillas (KALEMA-
ZIKUSOKA et al., 2002), ibex (LEON-VIZCAINO et al., 
1999), fox (FORCHHAMMER and ASFERG, 2000), and 
wombat (SKERRATT et al., 1999). 
Since the prevalence of the disease in man and 
animals is very high, the economic losses caused by the 
disease are enormous. Despite the huge economic 
losses, control measures that have been developed 
against this ectoparasite is limited. Until now, treating 
individual with clinical signs seems to be the most 
common method. This method is expensive and 
unpractical especially in animals. Topical scabicides is 
often uneffective, and very unpractical in animals 
especially when the number of animals to be treated is 
large. Injectable scabicides such as ivermectin is 
practical to use and usually effective for treatment 
clinical cases. However, this drug is expensive and 
intended for curative, not for preventive, purposes.  
Although ivermectin is currently the drug of choice 
for scabies, dissatisfaction regarding the use of this 
antiparasite chemical is escalating. The consumers are 
now demanding that the animal products be free from 
all chemical residues, whether or not the residues are 
known to be harmful to their health or to the immediate 
environment (DONALD, 1994). Ample evidence has 
already been available to indicate that this chemical is 
unsafe to human health and the environment. Death in 
human associated with the ivermectin has been reported 
(BARKWELL and SHIELDS, 1997; BREDAL, 1997; COYNE 
and ADDISS, 1997). It has also been demonstrated that 
animals injected with ivermectin contained the chemical 
in their excrement that killed a variety of important 
dung colonising insects (WALL, 1992). Prolonged and 
improper use of pesticides, including ivermectin, 
usually resulted in the development of parasite 
resistance against the pesticide. The occurance of 
resistance of S. scabiei aginst ivermectin has recently 
been reported (CURRIE et al., 2004).  
The increasing dissatisfaction against the use of anti 
parasite chemicals has provided the impetus to search 
for alternative means of parasite control. Vaccination 
seems to be an ideal alternative because it is practical, 
safe to the animals, consumers and the environment,
and it can be delivered with ease and potentially at low 
cost. However, developing antiparasite vaccines has 
proved to be much more difficult compared to antiviral 
or antibacterial vaccines. This is because interactions 
between the parasites and the host’s immune system are 
much more complex. The principal component of 
parasitic vaccine, unlike that of bacterial or viral 
vaccines, usually consists a single protein that has the 
capacity to confer protective immunity. One of the 
difficulties lies on finding this protective protein which 
has to be searched among huge number of parasite 
proteins.  
In our previous studies, both water-soluble and 
insoluble mite proteins were separated into several 
fractions, then the protective capacity of each fraction 
was evaluated in vaccination-challenge experiments. 
The experiments showed that none of the fraction has 
the capacity to induce protective immunity (TARIGAN, 
2005; TARIGAN and HUNTLEY, 2005). It is unknown for 
sure why we failed to identify the protective proteins. It 
may be that the protective antigens are present in an 
extreemly low concentration or the protective proteins 
had underwent inactivation due to denaturation or 
degradation during extraction or fractionation 
processes. One simple means to avoid protein 
denaturation and degradation is to rapidly extract and 
test the proteins. The purpose of this study, therefore, is 
to evaluate the protective capacity of freshly prepared 
mite proteins. 
MATERIALS AND METHODS 
Cultivation and collection of mites 
A goat displaying clinical signs of sarcoptic mange 
was purchased from a nearby farm and transported to 
the laboratory. After confirmation by microscopic 
examination that Sarcoptes scabiei is the only parasitic 
inhabitant of the skin, the goat was used to infest 
healthy goats by housing them together in an isolated 
pen. This colony of mangy goats was maintained as 
source of mites for immunogen preparation and 
challenge of vaccinated animals. Goats exhibited severe 
dermatitis were euthanised with a mixture of ether and 
chloroform. The coat was clipped and shaved, and skin 
showing encrustation dermatitis was scraped deeply. 
The skin scraping was chopped into approximately 2-
mm3 pieces, mixed thoroughly and kept at 4°C 
overnight. Mites were extracted using a previously 
described technique (TARIGAN, 1998). Briefly, the skin 
scrapings were placed at the edge of a Petri dish, and 
then a beam of light was directed to the centre of the 
Petri dish. Mites of all life stages crawling toward the 
light were collected by aspiration.  
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Preparation of soluble and insoluble mite proteins 
Freshly isolated mites (approximately 150 mg) were 
washed in a solution of 1% SDS in PBS, then 
homogenised in 10 ml Kanamycin-PBS (PBS 
containing 100 mg kanamycin sulphate/ml). A 2-ml 
portion of the slurry was mixed with 2 ml kanamycin-
PBS and referred to as fraction FTOT. The remaining of 
the homogenate was centrifuged at 10 000 x g for 10 
minutes then the supernatant was collected. A 3-ml 
portion of the supernatant was mixed with 1 ml 
kanamycin-PBS and referred to as fraction FSUP. After 
being completely depleted from supernatant the pellet 
was resuspended in 4 ml kanamycin-PBS and this 
mixture was referred to fraction FPEL. Each fraction was 
mixed (1:1) with a solution of Quil A (1 mg/ml in PBS) 
then injected immediately by intramuscular route into 
goats (1 ml per goats).  
Animals and vaccination 
Twenty-eight goats were randomly allocated into 4 
groups (7 goats per group). Group 1 goats were 
vaccinated with the fraction FTOT, Group 2 with the 
fraction FSUP, Group 3 with the fraction FPEL and Group 
4 with Kanamycin PBS and adjuvant only. Vaccination 
was conducted three times with three week intervals 
between vaccination, and each vaccination utilised 
freshly prepared mite protein fractions. 
Mite challenge and examination 
One week after the last vaccination, all animals 
were challenged with approximately 2000 live mites on 
the left auricles using a procedure described previously 
(TARIGAN, 2003). Briefly, skin scraping was collected 
from a mangy goat, chopped into about 2-mm3 pieces, 
and mixed thoroughly. The number of mite per gram of 
skin scraping was determined by placing the skin 
scraping at the edge of a Petri dish. A beam of light was 
directed to the centre of the Petri dish, and mites 
migrating toward the light were counted under a 
microscope after 6 hours. A piece of cloth (6 x 4 cm2) 
was placed on the convex surface of a goat auricle, the 
bottom, left and right rims of the cloth were attached to 
the auricle by an adhesive tape. Skin scrapings 
containing approximately 2000 mites were inserted 
under the cloth through the top edge then the top edge 
was attached to the auricle.  
After 48 hours, the cloth together with the skin 
scraping were removed and infestation was allowed to 
progress. Skin lesions caused by the mite challenge 
were photographed and their severity were assessed at 1 
and 2 days, then at weekly intervals from one to eight 
weeks. The severity of lesions was determined 
arbitrarily by the following scores: score 0 if no lesion, 
score 1 if <10% of the infested auricle was affected by 
the lesions, score 2 if 10-25%, score 3 if 25-50 %, score 
4 if < 50-75%, score 5 if >75% or other parts of the 
body were affected. The effect of mite infestation on 
body condition was assessed from the changes in the 
body weight which were measured weekly before and 
after challenge. 
ELISA 
Antigen for the ELISA was prepared according to 
ARLIAN et al. (1994). The contaminated IgG in the mite 
proteins was depleted by passing the solution through a 
Protein-G-sepharose column (Amersham Pharmacia). 
Optimal concentration of immunoreagents were 
determined by checkerboard titrations using a positive 
reference serum (pooled sera from vaccinated goats) 
and a negative reference serum (pooled sera from 
prevaccinated goats). Peroxidase-conjugated-anti-goat 
IgG (Jeckson Immuno Research Laboratories, West 
Grove, USA) was used as the secondary antibody, 
ABTS (Sigma chemicals) as chromogen and the 
reaction was measured at 405 nm. Antibody titre of a 
sample was expressed as the OD-ratio post-vaccinal or 
post challenge to pre-vaccinal serum. 
Immunoblotting 
Mites were homogenised in a Laemmli’s –reducing-
SDS-PAGE-sample buffer (65 mg/ml buffer). A 75 μl 
portion of the supernatant was loaded into a single-
sample-well-acrylamide plate (Protean II, BioRad). 
After electrophoresis, proteins from the acrylamide gel 
were transferred onto a nitrocellulose membrane 
(TARIGAN dan HUNTLEY, 2005). The membrane was cut 
into 5-mm-wide strips then soaked for 2 hours in a 
0.1% solution of non-fat skim milk to blocked 
unoccupied sites in the membrane. The strips were 
reacted for 2 hours with goat sera at 1:1000 dilution. 
Alkaline-phosphatase-labelled-anti-goat-mouse-
monoclonal antibody (Sigma) was used as detecting 
antibody and NBT/BCIP (Sigma) as substrates. 
Histopathology and Mite Burden 
At the end of challenge schedule (8 weeks after the 
initial mite infestation), the auricles were cut out at 5 
cm from the tip after they had been previously 
infiltrated with a local anaesthetic, Lidocaine-HCl. 
After the biopsy, the incision site was sutured, smeared 
with an antiseptic solution (Betadine®) and sprayed 
with a screw-worm-and-wound-dressing spray 
(Gusanex®). The detached auricle was cut into halves, 
one half was fixed in buffered formol saline for 
histology and the other half was stored at -20ΕC to be 
used for mite count. The histological samples were 
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paraffin blocked, processed routinely and sections were 
stained with Haematoxylin and Eosin (H&E). The skin 
from the auricles that had been stored at -20ΕC were 
scraped and the scrapes were suspended in 20% KOH 
solution (scrapes obtained from 2 cm2 skin were added 
to 1 ml KOH solution) for 30 minute. The scrape 
suspension was poured onto a 2-mm grid and the 
number of mites was counted under a light microscope.  
Statistical analysis  
The protective value of the immune response 
elicited by vaccination was based on the score of 
lesions, mite densities, titre of specific antibody 
measured by ELISA and changes in body weight. 
Differences in the score of lesions between group of 
goats were analysed using a non-parametric analysis, 
Kruskal-Wallis-one-way ANOVA (PETRIE and 
WATSON, 2001). Differences in the antibody titres, 
body weight changes and mite densities were analysed 
with a one-way ANOVA (PETRIE and WATSON, 2001). 
The data of mite densities which were expressed in 
number of mites/ cm2 were first transformed into their 
logarithmic values before analysed with a one-way 
ANOVA (PETRIE and WATSON, 2001). When 
differences between groups were statistically significant 
(P<0.05), Tukey’s multiple comparison analysis were 
performed.  
RESULTS 
Examination of the animals one and two days after 
challenge revealed that infestation was established in all 
animals. Some auricles became swollen with 
serocellular exudates oozed from the site of infestation, 
while others had numerous palpable small papules at 
the site of infestation. No differences were seen in the 
type or severity of lesions between group of goats. At 
one week, lesions developed into thick moist 
serocellular crusts or thin dry parakeratotic crusts with 
coats being fallen off at the site of infestation in all 
animals. In the following weeks, lesions progressed 
slowly. At four weeks, crusts of various thickness and 
alopecia were the most common lesions. In some 
animals, the crusts disappeared, leaving an area with 
alopecia but a healthy condition. At five weeks, 
however, the lesions seemingly reactivated as the area 
of encrustation dermatitis rapidly enlarged. 
Parakeratotic scales were formed in the alopecic skin 
that at previous weeks appered to recover. At eight 
weeks, the severity of lesions varied between animals. 
In the majority of animals, however, about halve the 
surface of infested auricles were affected and no 
significant differences between vaccinated and 
unvaccinated, or among the vaccinated groups were 
observed (Figure 1). 
The density of mites in the skin of infested auricles 
was presented in Figure 2. The mite densities were 
considerably low in all animals. Skin scraping collected 
even adjacent to the site of infestation contained no 
more than 5 mites/ cm2. Although the severity of lesions 
were comparable in all group of animals, the density of 
mites in the unvaccinated control goats was 
significantly higher than those in the vaccinated group 
(P=0.015).  
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Figure 1. Box-and-whisker plot of score of lesions on the infested auricles. The lesions were score from 0 if no lesions to 5 if the 
more than 75% of the auricle affected by encrustation dermatitis. The solid boxes denote 95% confidential interval (CI) of 
the median, empty boxes denote internal quarter (IQ) range, the horizontal line with a dot in the middle denotes the 
median. Note that the severity of lesions between group of goats were not significantly different (P>0.05) 
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Figure 2. Box-and-whisker plot of mite densities. The solid boxes denote 95% confidential interval (CI) of the median, empty 
boxes denote internal quarter (IQ) range, the horizontal line with a dot in the middle denotes the median of the total 
number of mites (all stage of development). Note that unvaccinated control goats (PBS) contained significantly higher 
number of mites (P=0.015) as compared to all vaccinated groups 
Measurements of specific antibody by ELISA one 
week after the third vaccination or at the time of mite 
challenge revealed that all vaccinated goats had high 
titre of specific antibodies. The ELISA’s OD of serum 
collected at the end of vaccination schedule increased to 
over six folds compared to that collected prior to 
vaccination (Figure 3). Unexpectedly, in the 
unvaccinated control animals, the titre of antibodies 
against mites also increased although the increase was 
much lower. Immunoblot analysis revealed that the 
banding pattern of these sera was different to that of 
infested animals (compare lines 1 post vaccination and 
post challenge, Figure 4). The immunoblot analysis also 
revealed that vaccination of goats with either mite 
homogenate, supernatant or pellet elicited antibodies 
that recognized a large number of mite proteins with 
molecular weights range from <14.3 to >220 kDa. Sera 
from naturally infested goats recognised a much smaller 
number of mite proteins and much less intense
reactions. The most prominent mite proteins recognised 
by these sera were those with molecular weight above 
66 kDa. The sera also recognised more than 10 proteins 
with molecular weight from 30 to 60 kDa although with 
less intense reaction. Apparently, no protein with 
molecular weight less than 30 kDa was recognised by 
the sera of infested animals. 
DISCUSSION 
This study shows that vaccination of goats with 
homogenates prepared from freshly isolated mites 
confered protective immunity against mite challenge. 
The protective immunity was indicated by inhibition of 
mite population in the vaccinated animals which albeit 
it was slight but statistically significant. Although the 
vaccination inhibited significantly the mite population, 
the severity of lesions, which was used as another 
indicator of protective immunity, were not affected.  
 
 
 
 
 
Figure 3. Box-and-whisker plot of mite densities of the ratio of OD Elisa after the third vaccination and before vaccination. The 
solid boxes denote 95% confidential interval (CI) of the median, empty boxes denote internal quarter (IQ) range, the 
horizontal line with a dot in the middle denotes the median 
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Figure 4. Immunoblot analysis of sera before vaccination, one week after the last (third) vaccination and 8 week after mite 
challenge. Line 1 represent pooled sera of unvaccinated control (PBS) goats, 2 = Total group (TOT), 3 = Supernatant 
group (SUP) and 4 = Pellet group (PEL) 
This may indicate that mite population is more sensitive 
as an indicator of protection in the vaccination-
challenge experiment than severity of lesions. 
In our previous experiments, infestation of goats 
with appoximately 2000 live mites produced scabious 
lesions that covered almost the entire surface of the 
infested auricles by 3 weeks, and practically the whole 
skin by 7 or 8 weeks after infestation ( TARIGAN, 2003, 
2005; TARIGAN and HUNTLEY, 2005). In the present 
study, however, infestation of unvaccinated control 
goats with similar number of mites produced much less 
severe lesions. In addition, the number of mites per cm2 
skin surface at the end of experiment were also much 
lower. The reason for the lower mite population and 
milder lesions was unknown. The animals were 
purchased from scabies-free farms and they did not 
show any signs of mite infestation before the mite 
challenge. In addition, their sera collected before 
vaccination did not recognise any scabies protein on 
ELISA and immunoblot assays. It is, therefore, unlikely 
that the reasons for the lower mite population and 
milder lesions in the control goats were specific 
immunity. The lower sensitivity was also unlikely due 
to breed differences because the goats used in the 
present study was the local or Kacang breed, similar to 
that used in the previous studies.  
In our previous studies, vaccination of goats with 
either soluble- or insoluble-mite-protein fractions failed 
to confer protective immunity despite the fact that the 
vaccinations induced strong humoral (IgG) immune 
responses (TARIGAN, 2005; TARIGAN and HUNTLEY, 
2005). The reason for the failure was unknown, it could 
be associated with inappropriate adjuvant or route of 
vaccination. Other possibilities include the protective 
antigens being present in extremely low abundance or 
having been degraded or denatured during the 
extraction or fractionation processes. In the present 
study, freshly isolated mites were rapidly hemogenised 
and injected into animals in order to prevent protein 
degradation and denaturation. The fact that vaccination 
with these fresh mite homogenates conferred protective 
immunity, albeit it was partial, indicates that the 
sarcoptic protective antigens are liable to degradation or 
denaturation. 
Although the animals in this study had been 
vaccinated three times, the vaccinations offered only 
limited protection. This may indicate that the sarcoptic 
protective antigens are not only liable to denaturation 
but also exist in a very low abundance. If this 
presumption proves to be true, identification and 
isolation of protective antigens, which consitute the 
most important steps in the vaccine development, will 
be very difficult. The conventional approach, in which 
complex parasite extracts are successively fractionated 
and the capacity of each fraction to induce protective 
immunity is determined by vaccination-challenge 
experiment, seems to be ineffective for S. scabiei. The 
ineffectiveness of this approach seems to be the most 
probable reason for the failure of identifying the 
sarcoptic protective antigens in our previous studies 
(TARIGAN, 2005; TARIGAN and HUNTLEY, 2005). 
Unlike in S.scabiei, the conventional approach has 
proved to be effective in the isolation of protective 
antigens from Boophilus microplus or Haemonchus 
contortus (KNOX et al., 1999; WILLADSEN et al., 1989). 
The effectiveness of the approach in those parasites 
could either be that their protective antigens are more 
resistant against denaturation, or exist in higher 
abundance or have higher ‘immunoprotectivity’. 
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Because of the inefficacy of the conventional 
approach, an alternative approach need to be sought to 
isolate the sarcoptic protective antigens. The protective 
antigens would be among the mite proteins that upon 
attacking by the host immune system resulted in the 
death or infertility of the mites. These proteins, in 
addition to having vital function for the mite survival, 
must be located in such location that could be reached 
by the effector component of the host immune system. 
Proteins lining the mite’s digestive tract or secreted 
digestive enzymes may be the best candidates. 
Targeting only those proteins, rather than the whole 
mite proteins as in the conventional approach, would be 
a more feasible approach. Initial studies aim at 
identifying and charaterisation of those proteins are 
required to facilitate their purification and evaluation of 
their protective immunogenicity. 
To sum up, goats vaccinated with fresh homogenate 
of S. scabiei developed partially protected immunity 
against mite challenge. The conferred immunity 
inhibited the mite growth but not the lesion 
development. The sarcoptic protective antigens are 
supposed to be liable to degradation and denaturation 
and exist in very low abundance or low antigenicity. 
The conventional approach, successively refined 
fractionation of complex mite extracts and vaccination-
challenge experiment, is not appropriate for isolation of 
the protective antigens. 
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